TSLA is around $400, capex is set to exceed $25B in 2026, and Q2 earnings are expected late July. Here’s what traders actually need to understand about the valuation math.
PLTR posted 85% revenue growth in Q1. The stock keeps falling anyway. Here’s what the valuation math, the analyst divide, and the NHS risk actually mean for traders right now.
Copper hit all-time highs in 2026. The miners haven’t fully priced what comes next.
Symbotic is no longer a story stock. The numbers are starting to say something different.
Kevin Warsh’s first FOMC press conference is today. The rate decision isn’t the story — the tone is.
Occidental Petroleum is up 38% in 2026. The setup behind it may have more room to run than the headlines suggest.
Bitcoin hit $126K in October 2025. Now it’s in the $60Ks. COIN, MSTR, and RIOT are trading like the cycle is over. It probably isn’t.
AVGO just posted record revenue and a $30B+ backlog. The real question is what the market has already priced in.
Diamondback Energy is generating free cash flow that most tech companies would envy — and almost nobody is talking about it the right way.
The Nuvalent acquisition is the biggest biopharma deal of the week — and it’s rewriting the playbook for lung cancer investing.
